Principal Investigator
Yanjie He
Zhujiang Hospital
Total Trials
2
As PI
2
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
BIOLOGICAL(2)
CART therapy in Acute myeloid leukemia(AML)
1 trial
not_applicable
zhujiang-hospitalCART therapy in Relapsed/Refractory multiple myeloma
1 trial
not_applicable
zhujiang-hospital2 unique interventions1 categories
Analytics
Trial Phases
No phase data
Trial Status
Terminated2
Role Distribution
Principal Investigator2
PI Rate100%
Activity Timeline
Clinical Trials (2)
CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia(AML)
PrincipalinvestigatorStart date: 2018-04-01
CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma(MM)
PrincipalinvestigatorStart date: 2018-03-01
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Zhujiang Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Xiequn Chen, M.D.
Xi'an No.3 Hospital
1 trials
Shared therapeutic areas:
Relapsed/Refractory Multiple Myeloma(MM)
Similarity Score15%
Lugui Qiu, MD
Institute of Hematology & Blood Diseases Hospital, China
2 trials
Shared therapeutic areas:
Relapsed/Refractory Multiple Myeloma(MM)
Similarity Score15%
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia(AML)
CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma(MM)
All 2 trials loaded